We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Plethora | LSE:PLE | London | Ordinary Share | GB00B06GL868 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.375 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
30/3/2015 14:13 | More worrying is the manufacturing problems of the 6 dose canister and the fact that Euro 6 million milestone payment from Recordati is dependant on that being solved! In fact the whole marketing strategy is based upon the 6 dose cannister working!! | henley2 | |
30/3/2015 14:07 | Yes, reads that way..exercise at 2p! | tsmith2 | |
30/3/2015 13:57 | Looks like there's going to be a massive dilution now. | mortimer7 | |
30/3/2015 13:44 | If your brought in under 6p your about to wish you never | brandy5911 | |
30/3/2015 13:44 | Oh well not good news in there | brandy5911 | |
30/3/2015 13:42 | Looks like this is about to get cheaper as per the results just released: BORROWINGS At 31 December 2014 the Group had total borrowings of GBP7,425,000 (2013: GBP9,267,000), full details of which are set out in Note 5. All the Company's loans are repayable on 31 March 2015. Under the terms of the refinancing agreements entered into during March 2013, the loan note holders have an option to convert these loans together with the associated accrued interest and redemption premium into ordinary shares at a rate of 2p per share. On the basis that the conversion option price is significantly less than the current market price, the board anticipates most of the Group's debt will be settled on or around 31 March 2015 through the issue of new ordinary shares. | mike111d | |
30/3/2015 13:37 | more cash needed ? | topsm4homos | |
30/3/2015 13:37 | not great results | topsm4homos | |
27/3/2015 07:55 | Brandy....no maybe about it. Been adding all week and will continue as 6p way too cheap. | duxy786 | |
20/3/2015 09:54 | May be a buying time again | brandy5911 | |
17/3/2015 11:42 | True Brandy5911, if the share price goes under 5pence I will buying some more shares. For now its sit and wait ! | adred | |
13/3/2015 11:50 | Not much happening hear for a long time | brandy5911 | |
12/3/2015 16:58 | What is 30 March all about, and why is CubeBoss stating Q2 launch, the company update clearly states: "The Company continues to expect EMA's Committee for Medicinal Products for Human Use (CHMP) approval for FORTACIN(TM) during Q3 2015. It is this marketing authorisation that will trigger the immediate commercial launch of the product in Europe by Recordati." So launch probably in Q4. and America is 2 years away if all goes to plan: "Clarifying and confirming the anticipated timelines relating to the NDA filing and potential approval of FORTACIN(TM) in the US. The Company expects to complete the filing of the FORTACIN(TM) NDA incorporating the new can size (6 doses, 3 sprays per dose) by Q4 2015 /Q1 2016. Once the filing has been made the Company anticipates a 10 month Prescription Drug User Fee Act review with commercial launch in the US expected in 2017." Have I missed an official communique from the company or are you just making stuff up. | bandflex | |
06/3/2015 18:09 | It's looking like the chart is finally breaking out of the downtrend. If volume picks up then it should consolidate further. Feels like relief at Rourke's Drift! | nashwan123 | |
06/3/2015 13:13 | Is this speculative buying ahead of March 30 anticipating an announcement? Could be a hell of a sell-off if no deal news is forthcoming. Fingers crossed! | richf75 | |
06/3/2015 10:36 | As you say, news will get this share moving; decided on a little top up at 6.6p | samplerboy | |
06/3/2015 10:31 | I agree Cube boss, we just need some newsflow to get the share price moving. | adred | |
06/3/2015 10:26 | We all know that Ricordati are launching our product in the 2nd Q And news on other licenses are very overdue!. Some huge buys over the last few days/weeks suggest we are going in the right direction. Happy holding, as this is a win win company.:0))) | cube boss | |
06/3/2015 09:10 | Good buying as of late; some going through at 6.47 marked as sells are in fact buys. This is a long term hold, hopefully spurred on by US news and/or EU news. | samplerboy | |
05/3/2015 22:47 | Well we know what aim is about - just saying if I can sell anything North of 30p in the next 2 years I will very pleased with my investment | brandy5911 | |
05/3/2015 18:56 | 30p would only give us a MC of around 200Mil, and with sales figures of around 1Billion a year from the US alone, 30p is Very Conservative! AIMO of course..;0) | cube boss | |
05/3/2015 14:08 | This needs massive us deal to push this much higher - otherwise it will spike to 12p then drop back down until some sales Buy out do 30p would make me very happy | brandy5911 | |
05/3/2015 13:32 | How many times we heard that one??? Disappointed here but still holding | leadersoffice |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions